Abstract
Purpose
To evaluate the feasibility and safety of transarterial embolization (TAE) using trisacryl gelatin microspheres (TGMs) for hypervascular tumors.
Materials and methods
This was a prospective multicenter clinical trial involving five institutions. TAE using TGMs was performed for hypervascular tumors in various locations. The primary endpoint was the technical success. The secondary endpoints included catheter accessibility, preservation of the feeding arteries, local tumor response based on the Response Evaluation Criteria in Cancer of the Liver (RECICL) and adverse events related to TAE based on the Common Terminology Criteria for Adverse Events, version 4.0.
Results
Twenty-three patients with liver tumors (n = 9), uterine fibroids (n = 3) and other tumors (n = 11) were enrolled. The technical success rate was 95.7 % (22 of 23 patients). Catheter accessibility and preservation of the feeding arteries were obtained in all 55 target vessels (100 %). Local tumor response rates were 46.7 and 55.8 % at 4 and 12 weeks, respectively. Eighteen (78.3 %) patients developed 53 symptomatic events including grade ≧3 events: hypertension 21.7 %, pain 8.7 %, vomiting 4.3 % and anorexia 4.3 %, all related to postembolization syndromes.
Conclusion
TAE using TGMs was technically feasible and safe for devascularization of hypervascular tumors.
Similar content being viewed by others
References
Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32:242–50.
Laurent A. Microspheres and nonspherical particles for embolization. Tech Vasc Interv Radiol. 2007;10:248–56.
Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2008;19:862–9.
Spies JB, Cornell C, Worthington-Kirsch R, Lipman JC, Benenati JF. Long-term outcome from uterine fibroid embolization with tris-acryl gelatin microspheres: results of a multicenter study. J Vasc Interv Radiol. 2007;18:203–7.
Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun JL, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol. 2012;165:156–64.
Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, et al. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. J Am Acad Dermatol. 2012;67:1025–39.
Kudo M, Kubo S, Takayasu K, Sakamoto M, Tanaka M, Ikai I, et al. Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version). Hepatol Res. 2010;40:686–92.
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.
Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr A. Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol. 2008;19:58–65.
Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2004;15:793–800.
Laurent A, Beaujeux R, Wassef M, Rüfenacht D, Boschetti E, Merland JJ. Tris-acryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. AJNR Am J Neuroradiol. 1996;17:533–40.
Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin YP, Aymard A, et al. Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evaluation in tumors and arteriovenous malformations. AJNR Am J Neuroradiol. 1996;17:541–8.
Laurent A, Wassef M, Chapot R, Houdart E, Merland JJ. Location of vessel occlusion of calibrated tris-acryl gelatin microspheres for tumor and arteriovenous malformation embolization. J Vasc Interv Radiol. 2004;15:491–6.
Worthington-Kirsch R, Spies JB, Myers ER, Mulgund J, Mauro M, Pron G, et al. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. 2005;106:52–9.
Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14:15–20.
Bonovac F, Ascher SM, Jones DA, Black MD, Smith JC, Spies JB. Magnetic resonance imaging outcome after uterine artery embolization for leiomyomata with use of tris-acryl gelatin microspheres. J Vasc Interv Radiol. 2002;13:681–7.
Scheurig C, Islam T, Zimmermann E, Hamm B, Kroencke TJ. Uterine artery embolization in patients with symptomatic diffuse leiomyomatosis of the uterus. J Vasc Interv Radiol. 2008;19:279–84.
Gaba RC. Chemoembolization practice patterns and technical methods among interventional radiologists: results of an online survey. AJR Am J Roentgenol. 2012;198:692–9.
Granberg D, Eriksson LG, Welin S, Kindmark H, Janson ET, Skogseid B, et al. Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors. Acta Radiol. 2007;48:180–5.
Stampful S, Stampfl U, Rehnitz C, Schnabel P, Satzl S, Christoph P, et al. Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part II: liver. Cardiovasc Intervent Radiol. 2007;30:462–8.
Erinjeri JP, Deodhar A, Thornton RH, Allen PJ, Getrajdman GI, Brown KT, et al. Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver. Cardiovasc Intervent Radiol. 2010;33:610–4.
Brown KT. Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol. 2004;15(2 Pt 1):197–200.
Tillou X, Boutemy F, Remond A, Petit J. Contribution of curative and preventive embolization for renal angiomyolipomas treatment. Prog Urol. 2010;20:627–32.
Deodhar A, Brody LA, Covey AM, Brown KT, Getrajdman GI. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol. 2011;22:795–9.
Basile A, Rand T, Lomoschitz F, Toma C, Lupattelli T, Kettenbach J, et al. Trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of bone neoplasms. Cardiovasc Intervent Radiol. 2004;27:495–502.
Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol. 2000;21:255–61.
Acknowledgments
We thank Hiraku Yodono, Tadashi Kimura and Takafumi Ichida for evaluation of the technical success as members of an independent assessment committee. This study was financially supported by Nippon Kayaku Co., Ltd. All study sites and institutions received funding from Nippon Kayaku for the clinical trial execution.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Yoshihiro Nambu is an employee of Nippon Kayaku. Yasuo Nakajima, Yasuaki Arai and Shinichi Hori received consultation and lecture fees from Nippon Kayaku. Miyuki Sone received a manuscript fee from Nippon Kayaku. Keigo Osuga received manuscript fees and will receive honoraria after publication for drafting of this manuscript from Nippon Kayaku.
Ethical statement
All procedures performed in studies involving human participants were in accordance with “good clinical practice” (GCP), all applicable subject privacy requirements and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
This study was registered with the JAPIC Clinical Trials Information Center (JapicCTI-101284) (http://www.clinicaltrials.jp/user/cteSearch_e.jsp).
About this article
Cite this article
Osuga, K., Nakajima, Y., Sone, M. et al. Transarterial embolization of hypervascular tumors using trisacryl gelatin microspheres (Embosphere): a prospective multicenter clinical trial in Japan. Jpn J Radiol 34, 366–375 (2016). https://doi.org/10.1007/s11604-016-0535-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-016-0535-5